Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study
出版年份 2022 全文链接
标题
Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study
作者
关键词
-
出版物
ONCOLOGIST
Volume 27, Issue 4, Pages 253-e312
出版商
Oxford University Press (OUP)
发表日期
2022-01-01
DOI
10.1093/oncolo/oyab078
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Phase II Study of Apatinib in Patients with Chemotherapy‐Refractory Advanced Or Metastatic Esophageal Squamous Cell Carcinoma ( ESO‐Shanghai 11)
- (2021) Li Chu et al. ONCOLOGIST
- Impact of PD-L1 combined positive score (CPS) on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma.
- (2021) Yuki Matsubara et al. JOURNAL OF CLINICAL ONCOLOGY
- Real-World Treatment Patterns and Outcomes in Patients Receiving Second-Line Therapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma
- (2020) Pranav Abraham et al. ADVANCES IN THERAPY
- Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II study
- (2020) Zhi-Qiang Wang et al. INVESTIGATIONAL NEW DRUGS
- Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
- (2019) Ming Yi et al. Molecular Cancer
- Anti-angiogenesis for cancer: Current status and prospects
- (2018) Massimo Russo et al. THROMBOSIS RESEARCH
- Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma
- (2017) Jianqiang Li et al. OncoTargets and Therapy
- Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer
- (2017) Miso Kim et al. Cancer Research and Treatment
- Efficacy and safety of angiogenesis inhibitors in small-cell lung cancer
- (2016) Heng Lin et al. Oncotarget
- The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients
- (2016) Weiwei Huang et al. Oncotarget
- Cetuximab plus pemetrexed as second-line therapy for fluorouracil-based pre-treated metastatic esophageal squamous cell carcinoma
- (2015) Jing Tian et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma
- (2013) Xuyuan Li et al. MEDICAL ONCOLOGY
- Effects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model
- (2012) Na Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Paclitaxel-Carboplatin Alone or with Endostar for Advanced Non-small Cell Lung Cancer
- (2011) Baohui Han et al. Journal of Thoracic Oncology
- The Essential Role of Fibroblasts in Esophageal Squamous Cell Carcinoma–Induced Angiogenesis
- (2008) Kazuhiro Noma et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started